SAMSUNG PHARM. Co., Ltd.
001360.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$129.51B
Close$
Share Statistics
| Market cap | $129.51 Billion |
|---|---|
| Enterprise Value | $144.98 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $122.66 |
| Beta | 0.76 |
| Outstanding Shares | 94,120,296 |
Return
| Return on Equity | -189.80% |
|---|---|
| Return on Assets | -113.28% |
| Return on Invested Capital | -20.78% |
Valuation & Multiples
| P/E Ratio | -0.95 |
|---|---|
| PEG | 0.5 |
| Price to Sales | 2.86 |
| Price to Book Ratio | 1.69 |
| Enterprise Value to Revenue | 3.39 |
| Enterprise Value to EBIT | -8.63 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SAMSUNG PHARM. Co., Ltd.
240 employees
CEO: Sung Tag Jung SAMSUNG PHARM. Co., LTD. is a South Korean pharmaceutical company engaged in the manufacturing and distribution of a wide array of medical products. Its extensive portfolio includes a variety of prescription medications, encompassing tre...